- Home
- OSW vs QURE Comparison
OSW vs QURE Comparison
Compare OSW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSW
- QURE
- Stock Information
- Founded
- OSW 2017
- QURE 1998
- Country
- OSW Bahamas
- QURE Netherlands
- Employees
- OSW N/A
- QURE N/A
- Industry
- OSW Hotels/Resorts
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- OSW Consumer Discretionary
- QURE Health Care
- Exchange
- OSW Nasdaq
- QURE Nasdaq
- Market Cap
- OSW 2.1B
- QURE 1.9B
- IPO Year
- OSW N/A
- QURE 2007
- Fundamental
- Price
- OSW $20.38
- QURE $27.54
- Analyst Decision
- OSW Strong Buy
- QURE Strong Buy
- Analyst Count
- OSW 3
- QURE 13
- Target Price
- OSW $24.33
- QURE $62.33
- AVG Volume (30 Days)
- OSW 572.4K
- QURE 4.7M
- Earning Date
- OSW 10-29-2025
- QURE 11-10-2025
- Dividend Yield
- OSW 0.98%
- QURE N/A
- EPS Growth
- OSW 40.79
- QURE N/A
- EPS
- OSW 0.70
- QURE N/A
- Revenue
- OSW $936,080,000.00
- QURE $15,751,000.00
- Revenue This Year
- OSW $8.69
- QURE N/A
- Revenue Next Year
- OSW $8.55
- QURE $229.18
- P/E Ratio
- OSW $29.14
- QURE N/A
- Revenue Growth
- OSW 7.27
- QURE N/A
- 52 Week Low
- OSW $14.21
- QURE $5.86
- 52 Week High
- OSW $23.49
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- OSW 44.45
- QURE 33.96
- Support Level
- OSW $19.22
- QURE $26.76
- Resistance Level
- OSW $20.86
- QURE $29.99
- Average True Range (ATR)
- OSW 0.68
- QURE 2.67
- MACD
- OSW -0.10
- QURE -0.10
- Stochastic Oscillator
- OSW 35.96
- QURE 37.32
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.